Top Section/Ad
Top Section/Ad
Most recent
Sfr4.9bn trade is largest European ECM deal since National Grid’s £7bn rights issue in 2024
Offer came as markets recovered and volatility fell
Abbott Laboratories plundered $20bn as it led a trio of drug companies which printed jumbo bonds as a deluge of supply in the dollar market ensured a red-hot end to the month.
More articles/Ad
More articles/Ad
More articles
-
The Federal Reserve cut interest rates two weeks before its regularly scheduled meeting in an attempt to boost confidence of markets severely impacted by Covid-19 fears. Market participants, however, tell GlobalCapital they worry that the bank is spending its ammunition too quickly to remedy a complicated issue that requires a medical solution, not a monetary one. -
Hopes of supply for senior and subordinated financial institution bonds have crumbled amid spread volatility, washed away by fears of the impact of Covid-19 coronavirus on bank balance sheets.
-
The most brutal equity market sell-off since the 2008 financial crisis rocked equity capital markets last week. But the primary market remains open, with investors open to block trades and the increased volatility benefitting convertible bonds, report Sam Kerr and Aidan Gregory.
-
The flow of money into bonds and equities in emerging markets in February slowed to its lowest level since the 'trade tantrum' last August, amid signs that the spread of the coronavirus has prompted a reassessment of country risk.
-
Europe's high grade corporate bond issuers are being pushed into tight issuing windows by volatility caused by the Covid-19 coronavirus. But investors are prepared for this and so far deals have found strong backing.
-
New emerging market bond issues have been assessed on a case-by-case basis this week as the spread of the Covid-19 virus delivered sharp swings in global markets. Some borrowers wanted to forge ahead in case of a further sell-off, while others prefer to wait for a recovery.
